EW vs ST · P/E 47, rev $1.39B vs P/E 150, rev $3.93B
Edwards Lifesciences Corp (EW) versus Sensata Technologies Holding NV (ST) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Sensata Technologies Holding NV (ST) is a scientific & technical instruments company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ST revenue for 2024-12-31 was $3.93B. Net income was $128.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. ST currently screens at market cap $7.19B and trailing P/E 149.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ST currently screens at market cap $7.19B and trailing P/E 149.9.
Not investment advice. Open the EW and ST stock pages for the full models.
Not investment advice.